-
EGFP mRNA m1Ψ: From Signal to Insight
2026-09-15
A mechanistic and translational framework for using Cap 1 EGFP mRNA containing N1-methylpseudouridine to separate delivery, translation, and protein-expression biology in reporter studies.
-
Cholesterol: Building Causal mRNA-LNP Assays
2026-09-15
Cholesterol is the principal sterol in membrane and lipid nanoparticle research, but its effects are often confounded by formulation variables. This guide presents an evidence-aware assay framework that connects cholesterol chemistry with the localized p21 mRNA-LNP findings in bladder cancer.
-
Angiotensin 1/2 (5-7) Workflow Guide
2026-09-14
Build reproducible cardiovascular, receptor-binding, and exploratory viral-interface assays with a defined H2N-Ile-His-Pro-OH peptide. This guide combines practical preparation, concentration scouting, controls, and troubleshooting while separating established findings from recommended workflow conditions.
-
Perifosine as an Akt Pathway Stress-Test
2026-09-14
Perifosine (KRX-0401) can serve as more than an oncology reagent: it is a chemical stress-test for linking Akt/mTOR signaling to apoptosis, Golgi stress, and treatment response. This article translates evidence from cancer models and cerebral ischemia/reperfusion research into a rigorous assay-design strategy.
-
Morning Training Improves Endurance Adaptation in Mice
2026-09-13
Hesketh et al. show that early-active-phase endurance training produces a faster improvement in treadmill performance than late-active-phase training in female mice, even when the early-training group completes less absolute work. The findings position exercise timing as an important experimental variable and connect performance adaptation with skeletal-muscle mitochondrial and contractile remodeling rather than with differences in terminal glycogen stores.
-
TMB for P. vivax Epitope Serology
2026-09-12
TMB converts HRP-linked antibody binding into a practical colorimetric signal for peptide ELISA, while also supporting peroxidase, tissue, enzyme, and redox assays. Applied to Plasmodium vivax epitope screening, it helps translate immunodominance findings into reproducible workflows for symptomatic and asymptomatic surveillance research.
-
BIRC2 and BIRC3 Regulation in Pulmonary Epithelium
2026-09-12
Thorne et al. distinguish the regulation of BIRC2 and BIRC3 in pulmonary epithelial models exposed to inflammatory cytokines and glucocorticoids. Their results position constitutive BIRC2 as a candidate rapid signaling regulator, whereas inducible BIRC3 may support later epithelial protection and inflammatory adaptation.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-11
This protocol establishes a standardized whole-blood platform for testing how metabolic interventions alter stimulus-specific cytokine responses. Its main practical value is the integration of fresh human blood, defined immune challenges, pathway-directed inhibitors, controls, and cytokine quantification into a workflow suited to comparative and cohort-based immunometabolism research.
-
AG-221: A Metabolic Stress-Test for IDH2 AML
2026-09-11
AG-221 (Enasidenib) can do more than suppress 2-hydroxyglutarate: it can function as a controlled metabolic perturbation in IDH2-mutant AML research. This article connects target engagement, differentiation, and CD44-dependent metabolic rewiring to practical assay design.
-
Mitochondrial Repair in Diabetic Periodontitis
2026-09-10
The reference study presents a hierarchically targeted, ROS-responsive nanoparticle hydrogel designed to repair mitochondrial dysfunction in M1 macrophages during diabetic periodontitis. Its combination of tuftsin-directed MPPT nanoparticles, MitoQ delivery, and ROS-cleavable local retention reduced inflammatory signaling and improved periodontal bone regeneration in a diabetic rat model.
-
N1-Methylpseudo-UTP for mRNA Workflows
2026-09-10
Build more controllable modified-RNA experiments with N1-Methylpseudo-UTP, from small-scale transcription screens to antigen and adjuvant mRNA studies. The workflow emphasizes matched controls, RNA integrity, and translation-focused validation rather than assuming that chemical modification alone determines biological performance.
-
Aneugen Mechanism Assay: Evidence from 27 Chemicals
2026-09-09
Bernacki and colleagues developed a tiered flow-cytometry strategy that separated tubulin stabilization, tubulin destabilization, and mitotic kinase inhibition across 27 reference chemicals. By combining multiparametric biomarkers with fluorescent Taxol responses and machine learning, the study provided a practical framework for mechanistic aneugenicity assessment.
-
GLP-1 (9-36) amide: Assay Workflow Guide
2026-09-09
Learn how to use GLP-1 (9-36) amide as a mechanistic blocking reagent in cAMP, receptor selectivity, and metabolic-cell assays. The workflow emphasizes peptide handling, matched controls, and careful interpretation of cross-reactive GLP-1 receptor signaling.
-
HNRNPU Lactylation Reprograms Serine Metabolism
2026-09-08
This Advanced Science study identifies HNRNPU K181 lactylation as a non-histone regulatory event that connects lactate accumulation with PHGDH expression, serine biosynthesis, and cervical cancer growth. Its combination of transcript, RNA-binding, metabolic, cellular, and in vivo evidence defines a lactylation–acetylation switch with potential value for studying metabolic dependencies, although pharmacological specificity and clinical transferability remain open questions.
-
Annexin V-PE Apoptosis Detection Kit Workflow
2026-09-08
Build faster apoptosis detection in live cells around phosphatidylserine externalization, with a 10-minute staining step suitable for flow cytometry and fluorescence microscopy. The workflow translates recent ALK-positive lymphoma findings into practical assay controls, pathway-focused sampling, and troubleshooting decisions.